Crack Cocaine
Crack is the freebase, smokable form of cocaine — the same drug pharmacologically, but because it is smoked rather than snorted, it reaches the brain faster and produces a shorter, more intense high that makes it more addictive. It shares cocaine's core risks (see the cocaine page for full detail) plus route-specific harms from smoking, and it carries a distinct US legal history: the crack/powder sentencing disparity.
Overview
Crack cocaine is cocaine that has been chemically converted from powder (cocaine hydrochloride) into a freebase form that can be smoked, produced as small, hard 'rocks' that make a crackling sound when heated — the source of the name. It is not a different drug from cocaine; the active compound is the same. What differs is the route: smoking crack, versus snorting powder cocaine, changes how fast and how intensely the drug acts, which is why crack developed a reputation for being especially addictive. For the full pharmacology, effects, and general risks of cocaine, see the cocaine page; this page focuses on what is specific to the crack form.
Source: NIDA; DEA; peer-reviewed literature (NIH/PMC)
Chemistry & mechanism of action
Crack acts through the same mechanism as powder cocaine — it blocks the reuptake of dopamine (and norepinephrine and serotonin), flooding the brain's reward circuitry (see the cocaine page for detail). The key difference is pharmacokinetic, not pharmacological: smoking delivers the drug to the brain within seconds via the lungs, producing a near-immediate, intense but short-lived rush, followed by a rapid crash. This fast onset and short duration drive a compulsive, repeat-dosing pattern that underlies crack's high addiction potential.
Source: NIDA; peer-reviewed literature (NIH/PMC)
Effects
The subjective effects are those of cocaine — euphoria, energy, alertness, confidence — but compressed and intensified by the smoking route: a rapid, powerful high lasting only minutes, followed by a sharp crash with craving, irritability, and low mood that pushes toward redosing. See the cocaine page for the full effect profile; what is specific to crack is the speed of onset, the brevity of the high, and the intensity of the crash-and-crave cycle.
Source: NIDA; peer-reviewed literature (NIH/PMC)
Risks & harms
Crack carries all of cocaine's risks — cardiovascular strain (heart attack, stroke, dangerous rhythms), overheating, seizures, and the danger of fentanyl contamination in the illicit supply (see the cocaine page) — plus harms specific to smoking it. Inhaling hot crack vapor damages the lungs: respiratory problems collectively called 'crack lung' (cough, chest pain, breathing difficulty, and acute lung injury) are well documented, and sharing pipes can transmit infections. The extremely fast, short high makes crack especially addictive, driving intense compulsive use and rapid escalation. The repeated crash-and-crave cycle contributes to binges that heighten the cardiovascular and psychological risks, including paranoia and stimulant psychosis. As with any illicit drug, crack cannot be assumed pure — cocaine and crack in the illicit market have been found adulterated, including with fentanyl, which can cause fatal overdose. If someone has chest pain, a very high temperature, seizures, trouble breathing, or collapses, call 911 immediately; naloxone should be given if an opioid such as fentanyl may be involved. This page has not yet been medically reviewed.
Source: NIDA; DEA; SAMHSA; peer-reviewed literature (NIH/PMC)
Legal status (US)
In the United States, crack cocaine is a Schedule II controlled substance — the same schedule as powder cocaine, reflecting an accepted (very limited) medical use alongside high abuse potential. Legally, the defining feature of crack is the historic sentencing disparity: under the Anti-Drug Abuse Act of 1986, federal penalties treated crack far more harshly than powder cocaine, with a 100-to-1 quantity ratio (it took 100 times more powder than crack to trigger the same mandatory-minimum sentence), a disparity widely criticized for its racially disproportionate impact. The Fair Sentencing Act of 2010 reduced that ratio to 18-to-1, and the First Step Act of 2018 made those reductions retroactive; efforts to eliminate the disparity entirely have continued. Follow local law; consult DEA and federal resources for specifics. This page has not yet been medically reviewed.
Source: DEA; US federal law (Anti-Drug Abuse Act 1986; Fair Sentencing Act 2010; First Step Act 2018)
Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling — penalties can be severe, including imprisonment.
Before you travel
Verify current rules with the destination country’s official drug authorityand your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.
If you’re detained or arrested abroad
Contact your own country’s embassy or consulatein the destination immediately — notthe destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →
Images
Visual references coming soon.
If it’s too intense
If an experience becomes overwhelming, the goal is to stay safe and let it pass — most difficult experiences ease as the drug wears off.
- Get to a calm, safe space with someone you trust who is sober and can stay with you.
- Cool down if you’re overheating — move somewhere cool, remove extra layers, rest. Overheating is especially a risk with stimulants and MDMA.
- Sip water to thirst — but don’t over-hydrate. Drinking large amounts of plain water (especially after MDMA) can dangerously dilute your blood sodium (hyponatremia). Electrolytes help more than volume.
- Slow your breathing — long, slow exhales help settle a racing heart and anxiety.
- A sugary drink, fruit juice, or a snack can ease shakiness and the anxiety that comes with low blood sugar.
- Do not take more, and do not add another substance to manage it. Redosing or adding something else (including a sedative like a benzodiazepine) can make things worse, not better.
With stimulants, overheating and a racing heart are the main concerns — get somewhere cool, stop any physical activity, and don't take more.
Source: general harm-reduction guidance from SAMHSA, NIH/NIDA, and MedlinePlus, in our own words. Draft — not yet medically reviewed.
Forensic dossier
Draft · every field is source-cited or marked “Unknown — pending review”Identity
- PubChem CID
- 446220PubChem PUG-REST ↗ · retrieved 2026-06-18
- IUPAC name
- methyl (1R,2R,3S,5S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylatePubChem PUG-REST ↗ · retrieved 2026-06-18
- Molecular formula
- C17H21NO4PubChem PUG-REST ↗ · retrieved 2026-06-18
- SMILES
- CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OCPubChem PUG-REST ↗ · retrieved 2026-06-18
- InChIKey
- ZPUCINDJVBIVPJ-LJISPDSOSA-NPubChem PUG-REST ↗ · retrieved 2026-06-18
- Synonyms / aliases
- crack, rock, cocaine, Benzoylmethylecgonine, Neurocaine, L-Cocaine, Kokain, Cocain, (-)-Cocaine, Cocaina, beta-Cocain, Methyl BenzoylecgoninePubChem PUG-REST + seed aliases ↗ · retrieved 2026-06-18
Composition
- Composition
- N/A — single compound (see Identity)
Physical / pill characteristics
- Dosage form
- Unknown — pending review (no Rx/OTC label; illicit — pill visuals = FIRST-PARTY submissions only, never generated or scraped)
- Route
- Unknown — pending review
- Shape
- Unknown — pending review
- Color
- Unknown — pending review
- Imprint
- Unknown — pending review
- Score
- Unknown — pending review
Scheduling & legal status
- US schedule
- Unknown — pending review
- International
- See EMCDDA/EUDA + WHO — synthesize per jurisdictionEMCDDA / EUDA ↗ · retrieved 2026-06-18
Effects
- Effects
- Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus ↗ · retrieved 2026-06-18
Risks
- Risks
- Cited source pending synthesis — author in our words from NIDA/MedlinePlus on review (NOT auto-generated)NIDA + MedlinePlus ↗ · retrieved 2026-06-18
Interactions
- Interactions
- Unknown — pending review
Dosage
Pending medical reviewer
